Cargando…

Advancing use of long‐acting and extended delivery HIV prevention and treatment regimens

Detalles Bibliográficos
Autores principales:	Delany‐Moretlwe, Sinéad, Flexner, Charles, Bauermeister, José A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338994/ https://www.ncbi.nlm.nih.gov/pubmed/37439079 http://dx.doi.org/10.1002/jia2.26126

Ejemplares similares

The importance of the “how”: the case for differentiated service delivery of long‐acting and extended delivery regimens for HIV prevention and treatment
por: Grimsrud, Anna, et al.
Publicado: (2023)

Advancing STI priorities in the SDG era: priorities for action
por: Chersich, Matthew F., et al.
Publicado: (2018)

‘I heard about this study on the radio’: using community radio to strengthen Good Participatory Practice in HIV prevention trials
por: Medeossi, Bonnie-Jeanne, et al.
Publicado: (2014)

‘It’s not about money, it’s about my health’: determinants of participation and adherence among women in an HIV-HSV2 prevention trial in Johannesburg, South Africa
por: MacPhail, Catherine, et al.
Publicado: (2012)

Long-Acting HIV Treatment and Prevention: Closer to the Threshold
por: Barnhart, Matthew
Publicado: (2017)

Advancing the use of Long‐Acting Extended Delivery formulations for HIV prevention in sub‐Saharan Africa: challenges, opportunities, and recommendations
por: Mgodi, Nyaradzo M., et al.
Publicado: (2023)

Recent Advances in Long-Acting Drug Delivery and Formulations
por: Al Fatease, Adel, et al.
Publicado: (2023)

Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa
por: Hosek, Sybil, et al.
Publicado: (2016)

Investing in the future: lessons learnt from communicating the results of HSV/ HIV intervention trials in South Africa
por: Delany-Moretlwe, Sinead, et al.
Publicado: (2011)

Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps and research priorities
por: Nachman, Sharon, et al.
Publicado: (2019)

‘Leaving no one behind’: reflections on the design of community-based HIV prevention for migrants in Johannesburg’s inner-city hostels and informal settlements
por: Scorgie, Fiona, et al.
Publicado: (2017)

The effect of HIV prevention products on incentives to supply condomless commercial sex among female sex workers in South Africa
por: Quaife, Matthew, et al.
Publicado: (2018)

Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies
por: Hobson, James J., et al.
Publicado: (2019)

Ultra-long-acting removable drug delivery system for HIV treatment and prevention
por: Kovarova, Martina, et al.
Publicado: (2018)

“You talk about problems until you feel free”: South African adolescent girls’ and young women’s narratives on the value of HIV prevention peer support clubs
por: Baron, Deborah, et al.
Publicado: (2020)

Bidirectional links between HIV and intimate partner violence in pregnancy: implications for prevention of mother-to-child transmission
por: Hatcher, Abigail M, et al.
Publicado: (2014)

Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials: a modelled economic evaluation and threshold analysis
por: Jamieson, Lise, et al.
Publicado: (2022)

The cost‐effectiveness of multi‐purpose HIV and pregnancy prevention technologies in South Africa
por: Quaife, Matthew, et al.
Publicado: (2018)

The impact of conditional cash transfers for HIV prevention on peer relationships: perspectives from female recipients and non-recipients in HPTN 068
por: Ndimande-Khoza, Makhosazane Nomhle, et al.
Publicado: (2022)

Preferences for ARV-based HIV prevention methods among men and women, adolescent girls and female sex workers in Gauteng Province, South Africa: a protocol for a discrete choice experiment
por: Quaife, Matthew, et al.
Publicado: (2016)

Oropharyngeal HPV infection: prevalence and sampling methods among HIV-infected men in South Africa
por: Chikandiwa, Admire, et al.
Publicado: (2018)

HIV pre‐exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery
por: Celum, Connie L, et al.
Publicado: (2019)

Cognitive mapping: using local knowledge for planning health research
por: Stadler, Jonathan, et al.
Publicado: (2013)

Rethinking HIV prevention to prepare for oral PrEP implementation for young African women
por: Celum, Connie L, et al.
Publicado: (2015)

Estimating the Cost-Effectiveness of Pre-Exposure Prophylaxis to Reduce HIV-1 and HSV-2 Incidence in HIV-Serodiscordant Couples in South Africa
por: Jewell, Britta L., et al.
Publicado: (2015)

Harnessing nanostructured systems for improved treatment and prevention of HIV disease
por: Monroe, Maya, et al.
Publicado: (2018)

A new paradigm for antiretroviral delivery: long-acting cabotegravir and rilpivirine for the treatment and prevention of HIV
por: Bares, Sara H., et al.
Publicado: (2022)

Using HPV vaccination for promotion of an adolescent package of care: opportunity and perspectives
por: MacPhail, Catherine, et al.
Publicado: (2013)

Collateral benefits: how the practical application of Good Participatory Practice can strengthen HIV research in sub‐Saharan Africa
por: Baron, Deborah, et al.
Publicado: (2018)

Long-acting injectable antiretrovirals for HIV treatment and prevention
por: Spreen, William R., et al.
Publicado: (2013)

Advances in nanomedicine drug delivery applications for HIV therapy
por: Curley, Paul, et al.
Publicado: (2017)

At the Heart of the Problem: Health in Johannesburg’s Inner-City
por: Rees, Helen, et al.
Publicado: (2017)

Including pregnant and breastfeeding people in trials of novel LAED PrEP agents: perspectives from sub‐Saharan Africa community stakeholders
por: White, Rhonda R., et al.
Publicado: (2023)

Development of a tool to assess HIV prevention readiness of adolescent girls and young women in HPTN 082 study
por: Beauchamp, Geetha, et al.
Publicado: (2023)

The potential role of long-acting injectable cabotegravir–rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis
por: Phillips, Andrew N, et al.
Publicado: (2021)

Long-Acting Injectable Antiretroviral Agents for HIV Treatment and Prevention
por: Kim, Yeon-Sook
Publicado: (2021)

Prevalent, persistent anal HPV infection and squamous intraepithelial lesions: Findings from a cohort of men living with HIV in South Africa
por: Chikandiwa, Admire, et al.
Publicado: (2019)

Prevalence of anogenital HPV infection, related disease and risk factors among HIV-infected men in inner-city Johannesburg, South Africa: baseline findings from a cohort study
por: Chikandiwa, Admire, et al.
Publicado: (2017)

Long‐acting injectable cabotegravir: implementation science needed to advance this additional HIV prevention choice
por: Schmidt, Heather‐Marie Ann, et al.
Publicado: (2022)

Transgender Women’s Barriers, Facilitators, and Preferences on Tailored Injection Delivery Strategies to Administer Long-Acting Injectable Cabotegravir (CAB-LA) for HIV Pre-exposure Prophylaxis (PrEP)
por: Rael, Christine Tagliaferri, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_21lj1llsbbv174pn56h69ava81